Author
The University of Texas MD Anderson Cancer CenterORCID 0000-0003-4242-1762Unclaimed ORCID profile · follow to get notified of new preprints
4 papers
Recent·Most cited
Neetu Singh, Esther Need, Ayden Berndt…·Sixiang Shi
This study demonstrates that FOLR1-targeted Actinium-225 alpha-particle therapy effectively treats ovarian cancer with high tumor regression and survival rates while minimizing toxicity.
Christopher M. Tarney, Paulette Y. Mhawech-Fauceglia, Jonathan D. Ogata…·Nicholas W. Bateman
The paper identifies conserved protein alterations and elevated MUC16 in low-grade serous ovarian cancers through quantitative proteomics and validation across multiple datasets.
Dan Li, Sixiang Shi, Qizhen Cao…·Chun Li
The paper shows that CuS nanoparticle-mediated photothermolysis of ovarian cancer cells enhances dendritic cell activation and T cell expansion compared to ionizing radiation.
Yujie Jiang, Matthew D. Montierth, Kaixian Yu…·Wenyi Wang
The paper develops CliPP to estimate subclonal mutation load (sML) and shows it predicts survival and immunotherapy response in cancers with low to moderate TMB.